Pharma Executives Set to Converge with Trump to Advocate for Revised Drug Policies

In a significant development for the pharmaceutical industry, top executives are preparing for a high-stakes meeting with former President Donald Trump on a forthcoming Monday. This gathering aims to address potential adjustments to drug pricing and supply policies that have sparked debate across the healthcare landscape.

Continue reading